#Therapeutics #LifeActive Bio #Molecular Admin

LifeActive Bio: A Game Changer in Therapeutic Delivery

LifeActive Bio, a pioneering biomaterials company based in San Carlos, California, recently unveiled their groundbreaking technology known as the Molecular Administration Platform™. This innovative system is designed to enhance how therapeutic compounds are delivered and absorbed by the human body, offering exciting possibilities for various healthcare applications.

Revolutionizing Nutrient Delivery

The primary aim of LifeActive Bio is to extend the overall quality of human life. By transitioning from traditional methods of drug delivery to a more advanced approach, the company seeks to reformulate therapeutics to improve absorption through the skin. The Molecular Administration Platform™ utilizes a natural lipo-surfactant microemulsion serum, which works by dynamically encapsulating molecules. This unique delivery system enables direct absorption, allowing for efficient transportation of therapeutic agents into the bloodstream without the need for invasive procedures.

Addressing Multiple Therapeutic Areas

The technology promises to cater to a wide range of healthcare domains, including cardiovascular health, metabolic disorders, mental wellness, oncology, and respiratory issues. This broad applicability is attributed to the platform's capability for polypharmacy and parenteral delivery, making it a versatile solution in the development of both biologics and small molecules.

Dex Morris, the founder and CEO of LifeActive Bio, expressed excitement about the potential of their molecular delivery platform: "We are committed to developing transformative methods to ensure that essential nutrients reach the body effectively. Our innovative approach offers new possibilities for both existing and new therapeutics."

Successful Preclinical Studies

LifeActive Bio has conducted a series of preclinical trials to evaluate the efficacy and safety of their platform. Initial studies, particularly those assessing cognitive enhancement, have shown promising results. In one trial, participants exhibited a notable 44% improvement in executive function, with 66% reporting enhanced calmness and an impressive 83% improvement in sleep quality. Additionally, other ongoing trials are monitoring sustained improvements in vital signs, including blood pressure and heart rate.

Dr. Scott Jenkins, Chief Scientific Officer of LifeActive Bio, emphasized the significance of their breakthrough technology: